Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia

Journal of Medical Genetics

Volumn 41, Issue 1, 2004, Pages 21-24

  Aucan, C ^a   Walley, A J ^a   Hill, A V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CARRIER PROTEIN;

ALLELE; ALZHEIMER DISEASE; ANEMIA; ARTICLE; BRAIN MALARIA; CARDIOVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; GAMBIA; GENOTYPE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MARKER GENE; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TH1 CELL; TRIACYLGLYCEROL BLOOD LEVEL;

PLASMODIUM FALCIPARUM;

EID: 1642574237     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2003.011981     Document Type: Article

References (19)

1. Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994;45:249-302.
2. Gregg RE, Brewer Jr HB. The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans. Clin Chem 1988;34(8B):B28-32.
3. Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 1988;42(1):104-12.
4. Mamotte CD, Sturm M, Foo JI, van Bockxmeer FM, Taylor RR. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol 1999;276(3):E553-7.
5. Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003;84(6):1215-36.
6. Mahley RW, Rail Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-37.
7. Gerdes LU, Gerdes C, Kervinen K, Savolainen M, Klausen IC, Hansen PS, et al. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation 2000;101(12):1366-71.
8. Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck CJ. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 1982;23(8):1224-35.
9. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell Jr PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7(2):180-4.
10. Wozniak MA, Faragher EB, Todd JA, Koram KA, Riley EM, Itzhaki RF. Does apolipoprotein E polymorphism influence susceptibility to malaria? J Med Genet 2003;40(5):348-51.
11. Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998;7(3):533-40.
12. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991;352(6336):595-600.
13. Day DJ, Speiser PW, Schulze E, Bettendorf M, Fitness J, Barany F, et al. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 1996;5(12):2039-48.
14. Shcherbak NS. Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study. BMC Med Genet 2001;2(1):8.
15. Aucan C, Walley AJ, Hennig BJ, Fitness J, Frodsham A, Zhang L, et al. Interferon-alpha receptor-1 (IFNAR1) variants are associated with projection against cerebral malaria in the Gambia. Genes Immun 2003;4(4):275-82.
16. Hosmer DW, Lemeshow S. Applied logistic regression. In: Assessing the fit of the model. New York: Wiley, 1989:135-75.
17. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O, Dyerberg J. The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet 1996;98(5):546-50.
18. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, et al. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 1998;7(9):1511-16.
19. Shakibaei M, Frevert U. Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans. J Exp Med 1996;184(5):1699-711.